Breaking Houthi Attacks Escalate, Threatening Saudi Oil Exports and Global Fuel Prices Driver Charged With Murder After Fatal Bus Collision in Los Angeles U.S. Military Aid Reallocated to Latin America for Narcoterrorism Fight Florida Republican Congresswoman Criticizes Trump’s Immigration Policies ICE Agent Christian Castro Makes Court Appearance in Minnesota on Shooting Charges

Friday September 18, 2026

Reporter

Nuvation Bio Inc.

2Articles Published

4Communities Covered

Published Articles

Press Release

Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer

Sep 17

Press Release

Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer

Sep 15